A randomized phase III trial of DX-8951f (Exatecan Mesylate; DX) and Gemcitabine (GEM) vs. Gemcitabine alone in advanced pancreatic cancer (APC)
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4006-4006
◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4006-4006
◽
Keyword(s):
2007 ◽
Vol 25
(16)
◽
pp. 2212-2217
◽
2005 ◽
Vol 23
(16_suppl)
◽
pp. 4105-4105
◽
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. 4079-4079
Keyword(s):
2014 ◽
Vol 32
(15_suppl)
◽
pp. 4121-4121
◽
2021 ◽
Vol 39
(15_suppl)
◽
pp. 4119-4119
2010 ◽
Vol 28
(10)
◽
pp. 1645-1651
◽
Keyword(s):
Keyword(s):